1.
ACG Case Rep J
; 10(12): e01207, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38089538
RESUMO
Intravenous immunoglobulin (IVIG) is used to treat multiple conditions, one of which is Guillain-Barré syndrome. Despite its multiple benefits, IVIG can cause a wide variety of side effects, most of which resolve with supportive care. We present a case in which a patient with new-onset Guillain-Barré syndrome was treated with IVIG and subsequently developed an acute elevation in liver enzymes with positive hepatitis B serology.